Works matching DE "MULTIPLE myeloma treatment"

Results: 1795

Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: A case report.

Published in:

Hemodialysis International, 2013, v. 17, n. 4, p. 618, doi. 10.1111/j.1542-4758.2012.00757.x

By:

Gong, Dehua;
Ji, Daxi;
Zhang, Kaiyue;
Huang, Xianghua;
Huang, Gaoyuan;
Xu, Bin;
Liu, Zhihong

Publication type:

Article

Novel insights into the mechanism of action of lenalidomide.

Published in:

OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.28386

By:

Semeraro, Michaela;
Galluzzi, Lorenzo

Publication type:

Article

Jornada do Paciente com Mieloma Múltiplo no Brasil: Um Estudo Descritivo.

Published in:

Saúde Coletiva, 2025, v. 15, n. 95, p. 15694, doi. 10.36489/saudecoletiva.2025v15i95p15694-15711

By:

Gomes dos Santos, Ana Carolina;
Machado de Almeida, Ana Beatriz;
dos Santos Simão, Fernanda Cristina;
Melo, Nina;
Rosenburg Gioseffi, Janaína;
Augusto Fedozzi, Fábio;
Fonseca Pinto, Catherine Moura;
Hamerschlak, Nelson

Publication type:

Article

Developments in the treatment of multiple myeloma: overview and nursing implications.

Published in:

Nursing Standard, 2025, v. 40, n. 6, p. 54, doi. 10.7748/ns.2025.e12403

By:

Toland, Samantha

Publication type:

Article

Rare Myelomas: Sometimes When You Hear Hooves, It's a Zebra...

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 808

By:

GENTILI, SILVIA;
LONIAL, SAGAR

Publication type:

Article

Exploring the Clinical Decisions of US Community-Based Oncologists and Hematologists in the Management of Multiple Myeloma and Follicular Lymphoma.

Published in:

Oncology (08909091), 2010, p. 1

By:

Anderson, Kenneth C.;
Cheson, Bruce D.;
Czuczman, Myron S.;
Fonseca, Rafael;
Gregory, Stephanie A.;
Lonial, Sagar;
Love, Neil

Publication type:

Article

Educational Assessment and Credit Form.

Published in:: Oncology (08909091), 2010, p. 24
Publication type:: Article

Up-Front Management of Multiple Myeloma.

Published in:

Oncology (08909091), 2010, p. 8

By:

LONIAL, SAGAR;
ANDERSON, KENNETH C.;
FONSECA, RAFAEL;
LOVE, NEIL

Publication type:

Article

Overview: Management of Treatable but Incurable Cancers--The Multiple Myeloma and Follicular Lymphoma Cross-Sectional Case Survey.

Published in:

Oncology (08909091), 2010, p. 4

By:

LOVE, NEIL

Publication type:

Article

Multiple Myeloma in the Elderly: When to Treat, When to Go to Transplant.

Published in:

Oncology (08909091), 2010, v. 24, n. 11, p. 992

By:

Harousseau, Jean-Luc

Publication type:

Article

Solitary Extramedullary and Bone Plasmacytomas versus Multiple Myeloma with Extramedullary Manifestation.

Published in:

2010

By:

Nair, Bijay

Publication type:

Opinion

Tailoring Treatment for Multiple Myeloma Patients With Relapsed and Refractory Disease.

Published in:

Oncology (08909091), 2010, v. 24, n. 3, p. 22

By:

Richardson, Paul G.;
Laubach, Jacob;
Mitsiades, Constantine;
Schlossman, Robert L.;
Doss, Deborah;
Colson, Kathleen;
McKenney, Mary L.;
Noonan, Kimberly;
Warren, Diane L.;
Ghobrial, Irene M.

Publication type:

Article

Best Practices in the Management of Newly Diagnosed Multiple Myeloma Patients Who Will Not Undergo Transplant.

Published in:

Oncology (08909091), 2010, v. 24, n. 3, p. 14

By:

Niesvizky, Ruben;
Coleman, Morton;
Mark, Tomer

Publication type:

Article

Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma.

Published in:

Oncology (08909091), 2010, v. 24, n. 3, p. 7

By:

Stadtmauer, Edward A.

Publication type:

Article

Advances in Optimizing Therapy and Quality of Life for People With Hard-to-Treat Blood Cancers.

Published in:: Oncology (08909091), 2009, v. 23, n. 14, p. 1296
Publication type:: Article

Perifosine Fast-Tracked for the Treatment of Relapsed/Refractory Multiple Myeloma.

Published in:: Oncology (08909091), 2009, v. 23, n. 14, p. 1221
Publication type:: Article

Emerging Therapies for Multiple Myeloma.

Published in:

Oncology (08909091), 2009, v. 23, n. 5, p. 407

By:

Dingli, David;
Rajkumar, S. Vincent

Publication type:

Article

Bortezomib/Dexamethasone vs VAD as Induction Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Updated Data From IFM 2005/0 1 Trial.

Published in:

2008

By:

Harousseau, J. L.;
Mathiot, C.;
Attal, M.

Publication type:

Abstract

PRACTICE-CHANGING IMPLICATIONS TODAY.

Published in:

Oncology (08909091), 2008, p. 46

By:

Rosen, Steven T.

Publication type:

Article

Bortezomib-Based Treatment Produces Impressive Complete Response and Survival in Newly Diagnosed Multiple Myeloma.

Published in:: Oncology (08909091), 2008, v. 22, n. 8, p. 860
Publication type:: Article

Treatment Options for Newly Diagnosed Multiple Myeloma.

Published in:: Oncology (08909091), 2008, p. 4
Publication type:: Article

Novel Combination Therapies for Multiple Myeloma.

Published in:: Oncology (08909091), 2008, p. 25
Publication type:: Article

Novel Observations in Multiple Myeloma.

Published in:: Oncology (08909091), 2008, p. 29
Publication type:: Article

Treatment Options for Relapsed and/or Refractory Multiple Myeloma.

Published in:: Oncology (08909091), 2008, p. 14
Publication type:: Article

Introduction.

Published in:: Oncology (08909091), 2008, p. 3
Publication type:: Article

Dramatic Results Seen in Phase III Front-Line Multiple Myeioma Trials of Bortezomib-Based Therapy.

Published in:: Oncology (08909091), 2008, v. 22, n. 1, p. 80
Publication type:: Article

Continued Progress in Treatment Options for Multiple Myeloma: From Past to Present and Future.

Published in:

Oncology (08909091), 2007, v. 21, n. 12, p. 1511

By:

Richardson, Paul G.;
Mitsiades, Constantine S.;
Anderson, Kenneth C.

Publication type:

Article

Phase I Evaluation of Carfilzomib (PR-171) in Hematological Malignancies: Responses in Multiple Myeloma and Woldenstrom's Macroglobulinemia at Well-Tolerated Doses.

Published in:: 2007
Publication type:: Abstract

The Combination of Pegylated Liposomal Doxorubicin and Bortezomib Significantly Improves Time to Progression and Overall Survival of Patients With Relapsed! Refractory Multiple Myeloma Compared With Bortezomib: Updated Results From a Randomized Phase Ill Study.

Published in:: 2007
Publication type:: Abstract

Melphalan-Prednisone-Thalidomide Is Superior to Meiphalan-Prednisone in Patients ⩾ 75 Years of Age With Untreated Multiple Myeloma: Preliminary Results of the Randomized, Double-Blind, Placebo-Controlled IFM 01/01 Trial.

Published in:: 2007
Publication type:: Abstract

Next Steps in Myeloma Management.

Published in:

Oncology (08909091), 2007, v. 21, n. 7, p. 798

By:

Lonial, Sagar

Publication type:

Article

A New Era in the Management of Multiple Myeloma.

Published in:

Oncology (08909091), 2007, v. 21, n. 7, p. 800

By:

Kumar, Shaji;
Kyle, Robert A.

Publication type:

Article

Novel Therapeutic Avenues in Myeloma: Changing the Treatment Paradigm.

Published in:

Oncology (08909091), 2007, v. 21, n. 7, p. 785

By:

Ghobrial, Joanne;
Ghobrial, Irene M.;
Mitsiades, Constantine;
Leleu, Xavier;
Hatjiharissi, Evdoxia;
Moreau, Anne-Sophie;
Roccaro, Aldo;
Schlossman, Robert;
Hideshima, Teru;
Anderson, Kenneth C.;
Richardson, Paul

Publication type:

Article

Lenalidomide Plus Low-Dose Dexamethasone Produces Survival Advantage in Multiple Myeloma.

Published in:: Oncology (08909091), 2007, v. 21, n. 5, p. 616
Publication type:: Article

Novel Agents in First-Line Therapy for Myeloma.

Published in:

Oncology (08909091), 2005, v. 19, n. 12, p. 1551

By:

Jagannath, Sundar

Publication type:

Article

A peek into the atomic details of thalidomide's clinical effects.

Published in:

Nature Structural & Molecular Biology, 2014, v. 21, n. 9, p. 739, doi. 10.1038/nsmb.2882

By:

Bhogaraju, Sagar;
Dikic, Ivan

Publication type:

Article

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data.

Published in:

2020

By:

Campioni, M.;
Agirrezabal, I.;
Hajek, R.;
Minarik, J.;
Pour, L.;
Spicka, I.;
Gonzalez-McQuire, S.;
Jandova, P.;
Maisnar, V.

Publication type:

journal article

Proteasome inhibitor, bortezomib, for myeloma and lymphoma.

Published in:

International Journal of Clinical Oncology, 2007, v. 12, n. 5, p. 318, doi. 10.1007/s10147-007-0695-5

By:

Tobinai, Kensei

Publication type:

Article

The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 6, p. 771, doi. 10.1007/s00228-017-2227-1

By:

Oortgiesen, B.;
Roon, E.N.;
Joosten, P.;
Kibbelaar, R.;
Storm, H.;
Hovenga, S.;
Rees, B.;
Woolthuis, G.;
Veeger, N.;
Waal, E.G.;
Hoogendoorn, M.

Publication type:

Article

Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach.

Published in:

Bioinformatics, 2014, v. 30, n. 13, p. 1899, doi. 10.1093/bioinformatics/btu133

By:

Peng, Huiming;
Peng, Tao;
Wen, Jianguo;
Engler, David A.;
Matsunami, Risë K.;
Su, Jing;
Zhang, Le;
Chang, Chung-Che (Jeff);
Zhou, Xiaobo

Publication type:

Article

Extramedullary Pulmonary Manifestations of Relapsed/Refractory Multiple Myeloma: A Case Series and Brief Review of the Literature.

Published in:

Journal of Respiration (JoR), 2024, v. 4, n. 3, p. 177, doi. 10.3390/jor4030016

By:

Kumar, Sagar;
Mazloom, Anita;
Carter, Marialaina;
Manisha, FNU;
Polski, Jacek;
Alkharabsheh, Omar

Publication type:

Article

Anti-CD38 monoclonal antibody daratumumab enhances the overall response rate in patients with multiple myeloma.

Published in:

Pamukkale Medical Journal, 2024, v. 17, n. 3, p. 448, doi. 10.31362/patd.1427969

By:

Elver, Özde;
Aslan, Nevin Alayvaz;
Erol, Veysel;
Kendir, İsmail Can;
Güler, Nil

Publication type:

Article

In Brief.

Published in:: 2009
Publication type:: Abstract

Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.

Published in:

Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 80, doi. 10.33393/grhta.2021.2245

By:

Mario, Boccadoro;
Patrizia, Berto;
Sara, Bringhen;
Elena, Zamagni;
Patrizia, Tosi;
Nicola, Cascavilla;
Nicola, Giuliani;
Donato, Mannina;
Renato, Zambello;
Francesca, Patriarca;
Vittorio, Montefusco;
Mariella, Grasso;
Francesco, Di Raimondo;
Massimo, Offidani;
Maria Teresa, Petrucci;
Pellegrino, Musto

Publication type:

Article

A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma.

Published in:

Journal of Clinical Medicine, 2018, v. 7, n. 3, p. 55, doi. 10.3390/jcm7030055

By:

Yamamoto, Tomofumi;
Kosaka, Nobuyoshi;
Hattori, Yutaka;
Ochiya, Takahiro

Publication type:

Article

Takamatsu, H. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation. J. Clin. Med. 2017, 6, 91

Published in:: 2017
Publication type:: Correction Notice

Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 10017, doi. 10.3892/ol.2018.8559

By:

ShEN, Jiangtao;
Du, Xinru;
Zhao, Lingxiu;
Luo, Hui;
Xu, Ziyu

Publication type:

Article

Potent antitumor effect of combination therapy with sub‑optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 9450, doi. 10.3892/ol.2018.8501

By:

Kinoshita, Shiori;
Ri, Masaki;
Kanamori, Takashi;
Aoki, Sho;
Yoshida, Takashi;
Narita, Tomoko;
Totani, Haruhito;
Ito, Asahi;
Kusumoto, Shigeru;
Ishida, Takashi;
Komatsu, Hirokazu;
Iida, Shinsuke

Publication type:

Article

Bufalin induces DNA damage response under hypoxic condition in myeloma cells.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6443, doi. 10.3892/ol.2018.8091

By:

Fujii, Eri;
Inada, Yuki;
Kakoki, Misaki;
Nishimura, Nao;
Endo, Shinya;
Fujiwara, Shiho;
Wada, Naoko;
Kawano, Yawara;
Okuno, Yutaka;
Sugimoto, Toshiya;
Hata, Hiroyuki

Publication type:

Article

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6257, doi. 10.3892/ol.2018.8178

By:

Jin, Hong-Guang;
Wu, Guo-Zhen;
Wu, Guo-Hua;
Bao, Yong-Ge

Publication type:

Article